Atom Bioscience & Pharmaceutical

About:

Atom Bioscience is a clinical-stage biotechnology company.

Top Investors: Fortune Venture Capital, HongShan, Oriza Holdings, Fortune Capital, Kaitai Capital

Description:

Atom Bioscience is a clinical-stage biotechnology company developing new treatments for inflammatory and metabolic diseases such as chronic gout and non-alcoholic steatohepatitis.

Total Funding Amount:

$160M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Suzhou, Jiangsu, China

Founded Date:

2012-01-01

Contact Email:

hui.yang(AT)atpmbp.com

Founders:

William (Dongfang) Shi

Number of Employees:

11-50

Last Funding Date:

2023-10-16

IPO Status:

Private

Industries: